To investigate their pathogenicity, we evaluated antibody-mediated CNS pathology in vivo following intracerebral injection (ICI) of IgG1 myelin–specific MS rAbs plus HC into the thalamus of C57BL/6 PLP-EGFP mice (16). This evidence concerns the gene PLP1 and myeloid sarcoma.